Efficacy and Safety of Tirzepatide Once Weekly in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-CN)

Name: Efficacy and Safety of Tirzepatide Once Weekly in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Are Overweight With Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-CN)
Creator: Vivli
Published: 2026-03-13T17:41:25+08:00

DataCite Commons2026-03-13 更新2026-05-07 收录

肥胖症药物临床试验

体重管理疗效评估

数据链接：

https://search.vivli.org/doiLanding/studies/PR00012840/isLanding 数据链接链接失效反馈

官方服务：

资源简介：

This is a study of tirzepatide in Chinese participants without Type 2 Diabetes who have obesity or overweight.The main purpose is to learn more about how tirzepatide affects body weight.

提供机构：

Vivli

创建时间：

2026-03-13